Artemis II is NASA’s last Moon mission without Silicon Valley

SpaceX launched its IPO the same day the U.S. returned astronauts to the Moon for the first time in 54 years, underscoring private-space momentum and venture capital’s growing role. NASA’s legacy SLS/Orion program — the most powerful operational rocket, flown once as a test — remains costly and delayed, while NASA plans 2027 orbital rendezvous tests and potential landings in 2028 that will put pressure on SpaceX’s Starship (requiring a dozen+ launches to fuel) and Blue Origin’s lander. New NASA administrator Jared Isaacman has pivoted agency policy away from Gateway and SLS upgrades toward venture-backed landers, raising sector upside but also geopolitical risk as China aims for a crewed lunar landing by 2030.

Analysis

The NASA pivot toward commercial lunar landers creates a two‑speed market: legacy prime contractors will see durable franchise value in defense & space platforms, but near‑term revenue and margin growth will shift to agile private suppliers and launch services. Expect 12–36 month revenue compression for contractors tied to SLS upgrades as program optionality shifts to competitively awarded lunar lander contracts; this is not an immediate solvency issue but a multi‑year re‑rating risk as backlog composition changes.

Second‑order winners include specialist suppliers and services exposed to increased launch cadence and in‑orbit refueling infrastructure — ground fuels/logistics, cryogenic tank composites, and autonomous rendezvous software — which have higher operating leverage and easier VC funding pathways than heavy prime manufacturing. Conversely, large primes face sticky fixed cost bases (pensions, legacy manufacturing lines) that magnify margin downside if SLS utilization drops and political support weakens, creating an asymmetric return profile for shorts vs longs.

Catalysts cluster around narrow windows: 2027 Orion rendezvous tests and 2027–28 Starship/Blue Origin lander trials. Those discrete events will reprice contract awards and political support; a SpaceX technical success accelerates commercial award cadence (positive for small caps/ETFs linked to commercial space), while a high‑profile failure would briefly re‑anchor NASA spending to legacy primes and compress valuations of the new entrants despite longer‑term secular momentum.

Key Decisions for Investors

• Initiate a tactical short on BA (size 2–3% NAV) with a 12–36 month horizon; set stop at 15% adverse move. Rationale: flow of profitable commercial lunar work will reallocate away from SLS upgrades, pressuring backlog growth. Target 30–45% downside if SLS program utilization is curtailed or materially repriced; pair with a 6–12 month credit put spread to monetize time decay and cap gasoline premium risk.
• Pair trade: short BA / long FLY (equal notional, each 1.5% NAV) for 6–18 months. Rationale: Firefly is exposed to near‑term robotic lander and small‑launcher demand and will rerate on contract wins; small cap execution risk justifies limited sizing. Expected asymmetric payoff: 3x upside on FLY vs 1.3–1.5x downside protection on the BA short via stop discipline.
• Long LUNR (thematic exposure, 3–5% NAV) purchased on any pullback into 5–10% after Starship/Blue Origin test outcomes; hedge with a 12‑18 month 7–10% OTM put to limit downside. Rationale: commercial lunar infrastructure has multi‑year secular optionality; a successful 2027–28 bake‑off is a binary re‑rating event. Risk/reward: protected downside and 2–4x upside on a reacceleration of commercial contract awards.
• Defensive collar on LMT if maintaining exposure: buy 1yr 10% OTM puts and sell 25% OTM calls funded by ~60–70% call premium to cap cost. Rationale: preserves upside from defense budgets while limiting drawdown from program reallocation risk; target protection for a 12–24 month political funding uncertainty window.